Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

targeted therapy

  • Open Access
    PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes
    IOANNIS A. VOUTSADAKIS
    Cancer Genomics & Proteomics September 2024, 21 (5) 533-548; DOI: https://doi.org/10.21873/cgp.20470
  • Open Access
    Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma
    VLASTIMIL KULDA, JIRI POLIVKA, MARTIN SVATON, TOMAS VANECEK, MARCELA BURESOVA, KATERINA HOUFKOVA, MAHYAR SHARIF BAGHERI, TEREZA KNIZKOVA, BOHUSLAVA VANKOVA, JINDRA WINDRICHOVA, PETR MACAN, VACLAV BABUSKA and MARTIN PESTA
    Cancer Genomics & Proteomics July 2023, 20 (4) 404-411; DOI: https://doi.org/10.21873/cgp.20392
  • Open Access
    Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
    KATHRINE S. RALLIS, ALAN MATHEW GEORGE, ANNA MARIA WOZNIAK, CAROLA MARIA BIGOGNO, BARBARA CHOW, JOHN GERRARD HANRAHAN and MICHAIL SIDERIS
    Cancer Genomics & Proteomics July 2022, 19 (4) 390-414; DOI: https://doi.org/10.21873/cgp.20328
  • You have access
    β-Arrestin2 Inhibits the Apoptosis and Facilitates the Proliferation of Fibroblast-like Synoviocytes in Diffuse-type Tenosynovial Giant Cell Tumor
    CHENXI CAO, YAN ZHANG, JIN CHENG, FEI WU, XINGYUE NIU, XIAOQING HU, XIAONING DUAN, XIN FU, JIYING ZHANG, XIN ZHANG and YINGFANG AO
    Cancer Genomics & Proteomics May 2021, 18 (3 Suppl) 461-470; DOI: https://doi.org/10.21873/cgp.20272
  • Open Access
    Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations
    SAURABH YADAV, NAVONIL DE SARKAR, NIRAJ KUMARI, NARENDRA KRISHNANI, ASHOK KUMAR and BALRAJ MITTAL
    Cancer Genomics & Proteomics November 2017, 14 (6) 495-506;
  • Open Access
    Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA)
    RAFFAELE PALMIROTTA, DOMENICA LOVERO, ERICA SILVESTRIS, CLAUDIA FELICI, DAVIDE QUARESMINI, PAOLA CAFFORIO and FRANCO SILVESTRIS
    Cancer Genomics & Proteomics May 2017, 14 (3) 173-179;
  • Open Access
    TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing
    HUILI ZHENG, YAN WANG, CHUANNING TANG, LINDSEY JONES, HUA YE, GUANGCHUN ZHANG, WEIHAI CAO, JINGWEN LI, LIFENG LIU, ZHENCONG LIU, CHAO ZHANG, FENG LOU, ZHIYUAN LIU, YANGYANG LI, ZHENFEN SHI, JINGBO ZHANG, DANDAN ZHANG, HONG SUN, HAICHAO DONG, ZHISHOU DONG, BAISHUAI GUO, HE YAN, QINGYU LU, XUE HUANG and SI-YI CHEN
    Cancer Genomics & Proteomics May 2016, 13 (3) 231-238;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire